Fibrillation auriculaire - FA

CAEP Acute Atrial Fibrillation/Flutter Best Practices checklist, CJEM 2018;20(3):334-342

Liste de vérification des meilleures pratiques en matière de fibrillation et de flutter auriculaires aigus de l’ACMU, I.G Stiell and al, CJEM-JCMU, 2018, 1-9, DOI 10.1017/cem.2018.26

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation, Canadian Journal of Cardiology 36 (2020) 1847e1948

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen J Bax, Carina Blomström-Lundqvist, Giuseppe Boriani, Manuel Castella, Gheorghe-Andrei Dan, Polychronis E Dilaveris, Laurent Fauchier, Gerasimos Filippatos, Jonathan M Kalman, Mark La Meir, Deirdre A Lane, Jean-Pierre Lebeau, Maddalena Lettino, Gregory Y H Lip, Fausto J Pinto, G Neil Thomas, Marco Valgimigli, Isabelle C Van Gelder, Bart P Van Putte, Caroline L Watkins, ESC Scientific Document Group, European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 373–498, https://doi.org/10.1093/eurheartj/ehaa612

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation, RACE, NEJM, March 18, 2019, DOI: 10.1056/NEJMoa1900353

The RACE to Treat Atrial Fibrillation in the Emergency Department, NEJM, March 18, 2019, DOI: 10.1056/NEJMe1902341

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation, January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW. Circulation. 2019 Jan 28:CIR0000000000000665. doi: 10.1161/CIR.0000000000000665

Benefits of rhythm control and rate control in recent-onset atrial fibrillation. the hermes-af study. Alfonso Martín, Blanca Coll-Vinent, Coral Suero, Amparo Fernández-Simón, Juan Sánchez, Mercedes Varona, Manuel Cancio, Susana Sánchez, José Carbajosa, Francisco Malagón, Eugeni Montull, Carmen Del Arco

Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 2019 January 31


Anticoagulants

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2. PMID: 31475793

Anticoagulants oraux directs et warfarine dans la fibrillation auriculaire et la thromboembolie veineuse, INESS, avril 2019

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report, Chest. 2018 Aug 21. pii: S0012-3692(18)32244-X. doi: 10.1016/j.chest.2018.07.040. [Epub ahead of print]

Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials. Bennaghmouch N, de Veer AJWM, Bode K, Mahmoodi BK, Dewilde WJM, Lip GYH, Brueckmann M, Kleine E, Ten Berg JM. Circulation. 2018 Mar 13;137(11):1117-1129. doi: 10.1161/CIRCULATIONAHA.117.028513. Epub 2017 Nov 3.

FA secondaire

Decision aid for early identification of acute underlying illness in emergency department patients with atrial fibrillation or flutter. Scheuermeyer FX, Norena M, Innes G, Grunau B, Christenson J, Grafstein E, Barbic D, Barrett T. CJEM. 2019 Dec 20:1-8. doi: 10.1017/cem.2019.454. [Epub ahead of print] PMID: 31856926

RESULTS: Of 1,083 consecutive undifferentiated ED AFF patients, 400 (36.9%) had an acute underlying illness; they were older with more comorbidities. Modeling demonstrated that three predictors (ambulance arrival; chief complaint of chest pain, dyspnea, or weakness; CHA2DS2-VASc score greater than 2) identified 93% of patients with acute underlying illness (95% confidence interval [CI], 91-96%) with 54% (95% CI, 50-58%) specificity. The decision aid missed 28 patients; (7.0%) simple blood tests and chest radiography identified all within an hour of presentation.